BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4935344)

  • 1. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 4. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
    Prout TE
    Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 7. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Causes of death in diabetes mellitus].
    Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
    Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
    [No Abstract]   [Full Text] [Related]  

  • 9. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 10. A progress report on the University Group Diabetes Program.
    Prout TE
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 12. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C; Miller JP; Williamson JR
    Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
    [No Abstract]   [Full Text] [Related]  

  • 13. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

  • 14. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenformin and vascular complications of diabetes.
    Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies.
    Feldman R; Crawford D; Elashoff R; Glass A
    Adv Metab Disord; 1973; 2():Suppl 2:557-67. PubMed ID: 4720386
    [No Abstract]   [Full Text] [Related]  

  • 17. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
    Seltzer HS
    Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of early diabetes. The University Group Diabetes Program.
    Prout TE
    Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.